City Moves for 11 March 2013 | Who’s switching jobs

Annabel Denham
Follow Annabel
Royal London
The mutual life and pensions company has announced the appointment of Tracey Graham to its board as a non-executive director. Graham was previously chief executive at Talaris, and is currently non-executive director at RPS, Dialight, and Albemarle and Bond Holdings.

The bank’s commercial banking division has appointed John Freeney as managing director, head of corporate real estate. He has held a number of senior roles in leading international financial institutions, and joins from Henderson Global Investors, where he was head of its real estate debt team. Prior to that, he held a variety of senior roles at Bank of America Merrill Lynch.

Cushman and Wakefield
Jim Parker will join the real estate advisory firm as a senior member of its residential valuation and advisory team. He previously spent 12 years at HNG, where he was responsible for residential valuations and development. He is also a member of the Royal Institution of Chartered Surveyors and a registered valuer.

The City law firm has announced the appointment of Anthony Shatz as a partner in its corporate team. Shatz specialises in corporate transactional work with particular focus on the real estate sector. He joins from SJ Berwin, where he was a partner.

Legg Mason
The investment management company’s emerging markets firm, Esemplia, has made two senior hires to its investment team. Steve Triantafilidis joins as a principal and head of investments. He was previously managing director and head of global equities at Vontobel Asset Management. Michael Bourke, who has been appointed portfolio manager, joins from FPP Asset Management, where he was partner and portfolio manager in its global emerging markets equity team.

The law firm has appointed Erwan Le Douce-Bercot as a partner in its real estate practice in Paris. Le Douce-Bercot joins from Gide Loyrette Nouel, where he was a real estate partner.

Theresa Heggie has been appointed chief strategy and marketing officer at the healthcare company. She has over 20 years’ experience in the pharmaceutical industry, and has previously held senior positions at Janssen Pharmaceuticals and Baxter.